| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 1.03e-17 | 6 | 32 | 6 | GO:0005332 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 2.58e-16 | 17 | 32 | 7 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 6.67e-16 | 19 | 32 | 7 | GO:0015373 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 8.62e-16 | 9 | 32 | 6 | GO:0015185 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 3.23e-15 | 23 | 32 | 7 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 8.64e-15 | 26 | 32 | 7 | GO:0015296 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 5.10e-14 | 15 | 32 | 6 | GO:0140161 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 2.75e-13 | 19 | 32 | 6 | GO:0015355 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 1.02e-12 | 23 | 32 | 6 | GO:0005283 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | SLC6A1 GABRB2 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 SLC19A1 | 1.54e-12 | 151 | 32 | 9 | GO:0008509 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | SLC6A1 GABRB2 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 XPR1 | 4.75e-12 | 171 | 32 | 9 | GO:0015103 |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 4.77e-12 | 29 | 32 | 6 | GO:0005416 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.62e-11 | 35 | 32 | 6 | GO:0005343 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.74e-11 | 125 | 32 | 8 | GO:0015108 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.30e-11 | 81 | 32 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A1 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 SLC19A1 XPR1 | 6.37e-10 | 296 | 32 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.65e-10 | 119 | 32 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC6A1 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 ATP13A3 SLC19A1 | 7.38e-10 | 301 | 32 | 9 | GO:0022853 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A1 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 ATP13A3 SLC19A1 XPR1 | 2.22e-09 | 477 | 32 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A1 GABRB2 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 ATP10B ATP13A3 LMBRD1 SLC19A1 XPR1 SIDT1 | 3.19e-09 | 1289 | 32 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | symporter activity | 3.37e-09 | 150 | 32 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | taurine:sodium symporter activity | 3.74e-09 | 3 | 32 | 3 | GO:0005369 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 5.84e-09 | 90 | 32 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.39e-09 | 171 | 32 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.48e-08 | 105 | 32 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.14e-08 | 207 | 32 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.25e-08 | 208 | 32 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 3.73e-08 | 5 | 32 | 3 | GO:0005368 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A1 GABRB2 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 ATP13A3 SLC19A1 XPR1 SIDT1 | 1.28e-07 | 1180 | 32 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A1 GABRB2 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 ATP13A3 SLC19A1 | 2.69e-07 | 793 | 32 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.35e-07 | 293 | 32 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A1 GABRB2 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 XPR1 | 2.00e-06 | 758 | 32 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 7.22e-06 | 465 | 32 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 7.43e-06 | 664 | 32 | 8 | GO:0008324 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 9.13e-06 | 83 | 32 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | creatine transmembrane transporter activity | 1.49e-05 | 4 | 32 | 2 | GO:0005308 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 1.97e-05 | 33 | 32 | 3 | GO:0072349 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 4.94e-05 | 627 | 32 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.26e-04 | 61 | 32 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 5.44e-04 | 238 | 32 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.28e-03 | 775 | 32 | 6 | GO:0016746 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 1.60e-03 | 37 | 32 | 2 | GO:0016409 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 4.02e-03 | 59 | 32 | 2 | GO:0015932 | |
| GeneOntologyMolecularFunction | amino acid binding | 6.09e-03 | 73 | 32 | 2 | GO:0016597 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 6.93e-03 | 78 | 32 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 9.92e-03 | 94 | 32 | 2 | GO:0050660 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.16e-02 | 102 | 32 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.16e-02 | 102 | 32 | 2 | GO:0043178 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.20e-02 | 104 | 32 | 2 | GO:0016407 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid transport | 3.12e-12 | 28 | 32 | 6 | GO:0015812 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid reuptake | 4.77e-12 | 4 | 32 | 4 | GO:0051936 | |
| GeneOntologyBiologicalProcess | amino acid neurotransmitter reuptake | 9.95e-10 | 10 | 32 | 4 | GO:0051933 | |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 3.14e-09 | 38 | 32 | 5 | GO:0098810 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 1.60e-08 | 52 | 32 | 5 | GO:0001504 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.67e-08 | 195 | 32 | 7 | GO:0006865 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.61e-08 | 208 | 32 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid import | 6.76e-08 | 6 | 32 | 3 | GO:0051939 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.17e-07 | 259 | 32 | 7 | GO:0006836 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.76e-07 | 275 | 32 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | alkanesulfonate transmembrane transport | 1.89e-07 | 8 | 32 | 3 | GO:0042918 | |
| GeneOntologyBiologicalProcess | taurine transmembrane transport | 1.89e-07 | 8 | 32 | 3 | GO:0015734 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CYBB SLC6A1 GABRB2 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 ATP13A3 HEPHL1 SLC19A1 | 4.70e-07 | 1374 | 32 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CYBB SLC6A1 GABRB2 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 ATP13A3 SLC19A1 | 4.95e-07 | 1115 | 32 | 11 | GO:0034220 |
| GeneOntologyBiologicalProcess | modified amino acid transport | 6.20e-07 | 44 | 32 | 4 | GO:0072337 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 2.55e-06 | 410 | 32 | 7 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 2.64e-06 | 412 | 32 | 7 | GO:0015849 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 5.53e-06 | 167 | 32 | 5 | GO:1903825 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 9.70e-06 | 87 | 32 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.02e-05 | 88 | 32 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | organic anion transport | 1.14e-05 | 515 | 32 | 7 | GO:0015711 | |
| GeneOntologyBiologicalProcess | creatine transmembrane transport | 1.40e-05 | 4 | 32 | 2 | GO:0015881 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A1 GABRB2 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 XPR1 | 1.67e-05 | 1017 | 32 | 9 | GO:0098660 |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 3.45e-05 | 120 | 32 | 4 | GO:0003333 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A1 SLC6A2 SLC6A6 SLC6A8 SLC6A11 SLC6A12 SLC6A13 ATP13A3 HEPHL1 | 4.62e-05 | 1157 | 32 | 9 | GO:0006812 |
| GeneOntologyBiologicalProcess | organic cation transport | 7.23e-05 | 145 | 32 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 7.26e-05 | 942 | 32 | 8 | GO:0098655 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.10e-04 | 1000 | 32 | 8 | GO:0030001 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 1.39e-04 | 65 | 32 | 3 | GO:0072348 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 1.74e-04 | 344 | 32 | 5 | GO:0003018 | |
| GeneOntologyBiologicalProcess | import into cell | 1.81e-04 | 1074 | 32 | 8 | GO:0098657 | |
| GeneOntologyBiologicalProcess | acidic amino acid transport | 2.97e-04 | 84 | 32 | 3 | GO:0015800 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 3.17e-04 | 213 | 32 | 4 | GO:0015718 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 4.24e-04 | 230 | 32 | 4 | GO:0098739 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 4.40e-04 | 922 | 32 | 7 | GO:0098662 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.16e-03 | 134 | 32 | 3 | GO:0098661 | |
| GeneOntologyBiologicalProcess | innervation | 1.27e-03 | 34 | 32 | 2 | GO:0060384 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.70e-03 | 153 | 32 | 3 | GO:0098656 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 2.03e-03 | 163 | 32 | 3 | GO:1905039 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 2.69e-03 | 180 | 32 | 3 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.82e-03 | 183 | 32 | 3 | GO:0006820 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.74e-06 | 164 | 32 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 9.87e-05 | 1293 | 32 | 9 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 1.02e-04 | 1299 | 32 | 9 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 1.20e-04 | 1327 | 32 | 9 | GO:0042175 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.24e-04 | 583 | 32 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.48e-04 | 405 | 32 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | presynaptic membrane | 8.10e-04 | 277 | 32 | 4 | GO:0042734 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.38e-03 | 320 | 32 | 4 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.00e-03 | 354 | 32 | 4 | GO:0009925 | |
| GeneOntologyCellularComponent | presynapse | 2.01e-03 | 886 | 32 | 6 | GO:0098793 | |
| GeneOntologyCellularComponent | basal part of cell | 2.54e-03 | 378 | 32 | 4 | GO:0045178 | |
| GeneOntologyCellularComponent | postsynapse | 4.01e-03 | 1018 | 32 | 6 | GO:0098794 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 6.73e-16 | 18 | 32 | 7 | PS00754 | |
| Domain | SNF | 1.06e-15 | 19 | 32 | 7 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.06e-15 | 19 | 32 | 7 | PS50267 | |
| Domain | Na/ntran_symport | 1.06e-15 | 19 | 32 | 7 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.06e-15 | 19 | 32 | 7 | PS00610 | |
| Domain | - | 1.37e-03 | 32 | 32 | 2 | 2.70.150.10 | |
| Domain | - | 1.37e-03 | 32 | 32 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.63e-03 | 35 | 32 | 2 | IPR023299 | |
| Domain | ATPASE_E1_E2 | 1.73e-03 | 36 | 32 | 2 | PS00154 | |
| Domain | ATPase_P-typ_P_site | 1.73e-03 | 36 | 32 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 1.73e-03 | 36 | 32 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.82e-03 | 37 | 32 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.82e-03 | 37 | 32 | 2 | PF00122 | |
| Domain | - | 2.13e-03 | 40 | 32 | 2 | 3.40.630.30 | |
| Domain | Acyl_CoA_acyltransferase | 2.69e-03 | 45 | 32 | 2 | IPR016181 | |
| Domain | zf-RING_2 | 3.57e-03 | 52 | 32 | 2 | PF13639 | |
| Domain | - | 5.37e-03 | 64 | 32 | 2 | 3.40.50.1000 | |
| Domain | HAD-like_dom | 8.07e-03 | 79 | 32 | 2 | IPR023214 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.84e-13 | 19 | 22 | 6 | MM15107 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.84e-13 | 19 | 22 | 6 | M27362 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.40e-09 | 76 | 22 | 6 | MM15072 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.58e-09 | 84 | 22 | 6 | M27334 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 1.70e-08 | 19 | 22 | 4 | M927 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 1.70e-08 | 19 | 22 | 4 | MM15523 | |
| Pathway | WP_NRF2_PATHWAY | 5.89e-08 | 141 | 22 | 6 | M39454 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 5.40e-07 | 11 | 22 | 3 | M27681 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 5.40e-07 | 11 | 22 | 3 | MM15402 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 1.06e-06 | 51 | 22 | 4 | MM14499 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 1.06e-06 | 51 | 22 | 4 | M4281 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.29e-06 | 238 | 22 | 6 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.68e-06 | 249 | 22 | 6 | M5988 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 6.43e-06 | 314 | 22 | 6 | M39428 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 1.44e-05 | 31 | 22 | 3 | M39369 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.53e-05 | 211 | 22 | 5 | MM14502 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.01e-05 | 270 | 22 | 5 | M15514 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 5.37e-05 | 681 | 22 | 7 | MM14985 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 8.79e-05 | 736 | 22 | 7 | M27287 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.39e-04 | 335 | 22 | 5 | MM14503 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 2.13e-04 | 367 | 22 | 5 | M48346 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.59e-04 | 411 | 22 | 5 | M735 | |
| Pathway | KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS | 5.27e-04 | 22 | 22 | 2 | M11673 | |
| Pathway | WP_MONOAMINE_TRANSPORT | 1.12e-03 | 32 | 22 | 2 | M39724 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.12e-03 | 32 | 22 | 2 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.19e-03 | 33 | 22 | 2 | M188 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 2.41e-03 | 47 | 22 | 2 | M39853 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 2.94e-03 | 52 | 22 | 2 | MM15920 | |
| Pathway | WP_FERROPTOSIS | 4.42e-03 | 64 | 22 | 2 | M39768 | |
| Pathway | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | 6.26e-03 | 245 | 22 | 3 | MM15403 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 8.03e-03 | 87 | 22 | 2 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 8.21e-03 | 88 | 22 | 2 | M41810 | |
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 3.18e-17 | 21 | 32 | 7 | 16125675 | |
| Pubmed | Hypotaurine Is a Substrate of GABA Transporter Family Members GAT2/Slc6a13 and TAUT/Slc6a6. | 5.90e-13 | 4 | 32 | 4 | 30270321 | |
| Pubmed | 5.90e-13 | 4 | 32 | 4 | 8420981 | ||
| Pubmed | 2.95e-12 | 5 | 32 | 4 | 8956109 | ||
| Pubmed | 4.04e-12 | 18 | 32 | 5 | 18985723 | ||
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 24842606 | ||
| Pubmed | Astrocytic γ-aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain. | 7.07e-10 | 3 | 32 | 3 | 29175673 | |
| Pubmed | Developmental expression of the neurotransmitter transporter GAT3. | 7.07e-10 | 3 | 32 | 3 | 10348670 | |
| Pubmed | 3.61e-09 | 143 | 32 | 6 | 20424473 | ||
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 22896705 | ||
| Pubmed | 2.56e-07 | 14 | 32 | 3 | 23378610 | ||
| Pubmed | 2.94e-07 | 300 | 32 | 6 | 19086053 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 32301730 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 25256099 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 1400419 | ||
| Pubmed | Substrate-Na+ complex formation: coupling mechanism for gamma-aminobutyrate symporters. | 8.20e-07 | 2 | 32 | 2 | 19450549 | |
| Pubmed | Protein kinases as regulators of osmolyte accumulation under stress conditions: An overview. | 8.20e-07 | 2 | 32 | 2 | 32114438 | |
| Pubmed | Evidence for a Revised Ion/Substrate Coupling Stoichiometry of GABA Transporters. | 8.20e-07 | 2 | 32 | 2 | 25824654 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 26212582 | ||
| Pubmed | 2.17e-06 | 100 | 32 | 4 | 26073538 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 25103283 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 29370841 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 18690111 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 18975268 | ||
| Pubmed | 2.64e-06 | 105 | 32 | 4 | 30280653 | ||
| Pubmed | Characteristic development of the GABA-removal system in the mouse spinal cord. | 4.92e-06 | 4 | 32 | 2 | 24412234 | |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 6.18e-06 | 130 | 32 | 4 | 19874574 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 33009395 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 18334916 | ||
| Pubmed | 4.22e-05 | 212 | 32 | 4 | 19521566 | ||
| Pubmed | 6.30e-05 | 235 | 32 | 4 | 32614325 | ||
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 28112518 | ||
| Pubmed | 1.24e-04 | 18 | 32 | 2 | 31791063 | ||
| Pubmed | 1.55e-04 | 113 | 32 | 3 | 30352685 | ||
| Pubmed | 2.45e-04 | 132 | 32 | 3 | 26439863 | ||
| Pubmed | 3.05e-04 | 28 | 32 | 2 | 19352218 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 3.75e-04 | 31 | 32 | 2 | 18195088 | |
| Pubmed | 3.75e-04 | 31 | 32 | 2 | 37816598 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 4.10e-04 | 697 | 32 | 5 | 28298427 | |
| Pubmed | Liver and brain differential expression of one-carbon metabolism genes during ontogenesis. | 4.25e-04 | 33 | 32 | 2 | 34702858 | |
| Pubmed | 4.52e-04 | 34 | 32 | 2 | 33500475 | ||
| Pubmed | 5.07e-04 | 36 | 32 | 2 | 38070861 | ||
| Pubmed | Mapping of eight testis-specific genes to mouse chromosomes. | 5.07e-04 | 36 | 32 | 2 | 9403069 | |
| Pubmed | 6.07e-04 | 1168 | 32 | 6 | 19946888 | ||
| Pubmed | 7.08e-04 | 190 | 32 | 3 | 24816252 | ||
| Pubmed | Identification of APBB1 as a substrate for anaplastic lymphoma kinase. | 7.57e-04 | 44 | 32 | 2 | 39115278 | |
| Pubmed | 7.87e-04 | 197 | 32 | 3 | 36604605 | ||
| Pubmed | 8.57e-04 | 467 | 32 | 4 | 30194290 | ||
| Pubmed | 8.64e-04 | 47 | 32 | 2 | 18821565 | ||
| Interaction | RAB5C interactions | 2.83e-05 | 600 | 31 | 7 | int:RAB5C | |
| Interaction | GJD3 interactions | 5.77e-05 | 454 | 31 | 6 | int:GJD3 | |
| Interaction | TMEM41B interactions | 1.07e-04 | 162 | 31 | 4 | int:TMEM41B | |
| Interaction | RAC1 interactions | 1.55e-04 | 1063 | 31 | 8 | int:RAC1 | |
| Interaction | FADS2 interactions | 1.75e-04 | 71 | 31 | 3 | int:FADS2 | |
| Interaction | RPN1 interactions | 1.92e-04 | 814 | 31 | 7 | int:RPN1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p25 | 1.74e-04 | 155 | 32 | 3 | chr3p25 | |
| Cytoband | 5q34 | 2.30e-04 | 32 | 32 | 2 | 5q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q34 | 3.79e-04 | 41 | 32 | 2 | chr5q34 | |
| Cytoband | 3p25.3 | 4.57e-04 | 45 | 32 | 2 | 3p25.3 | |
| GeneFamily | Solute carriers | 1.75e-09 | 395 | 18 | 8 | 752 | |
| GeneFamily | Ring finger proteins | 3.00e-02 | 275 | 18 | 2 | 58 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.19e-05 | 198 | 32 | 4 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | critical|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.21e-05 | 199 | 32 | 4 | 16c55cb8a0e740342009965f0eddfb0ed2858fab | |
| ToppCell | NS-critical|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-05 | 199 | 32 | 4 | f7c14dc9a9e659f89352dccf8954d6cbada011ab | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 152 | 32 | 3 | 962f5bf632da79bd933193d3edd7d89941a85831 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 154 | 32 | 3 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 155 | 32 | 3 | d2e489a08b4e711bd2ed483dcc4da7dbbaa4feea | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 155 | 32 | 3 | cb456d6f13bfb5cb400c0840a0ab6ba4616dcf37 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 155 | 32 | 3 | a547fdcd974b0813ce6c8cccfec9fff74cac2d1a | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 156 | 32 | 3 | 5b56217336771baf57d791efcb4e206c6aea83b1 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.96e-04 | 158 | 32 | 3 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 2.07e-04 | 161 | 32 | 3 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.22e-04 | 165 | 32 | 3 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.22e-04 | 165 | 32 | 3 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.26e-04 | 166 | 32 | 3 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-04 | 166 | 32 | 3 | c8fd241088de27c6e741a5dfee3cd770183b6bcb | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.30e-04 | 167 | 32 | 3 | ecdbfde870a2a44c44b9dd65a8737afc6fbf816c | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 2.43e-04 | 170 | 32 | 3 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-04 | 170 | 32 | 3 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-04 | 171 | 32 | 3 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|Fibroblasts / Location, Cell class and cell subclass | 2.51e-04 | 172 | 32 | 3 | c3822ff7329c3ac38c68c5c38cd67c390682e2a6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 174 | 32 | 3 | 723848d2f8ae9cf4f15d4b4a130f9a64dab443c7 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-04 | 176 | 32 | 3 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-04 | 177 | 32 | 3 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.73e-04 | 177 | 32 | 3 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.73e-04 | 177 | 32 | 3 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-04 | 178 | 32 | 3 | afcc92e8fe313c85eaf617cf4dbc3058da6c99d6 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-04 | 178 | 32 | 3 | bd689205bc92cda5f71df64c2332ff76adcd84b4 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.82e-04 | 179 | 32 | 3 | 6d2458a887047b5c20389f08345ff5aac7c683e6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Mesenchymal-Mes|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 179 | 32 | 3 | 368f7e91e9c2c854c8778788cead022d158d1122 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Mesenchymal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 179 | 32 | 3 | 11e434fc49bc0a806197f21debcac8337e0502aa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 180 | 32 | 3 | f118c580134bdf3027e2218690cfc8a93468c1ae | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 180 | 32 | 3 | 1ade66352570a3f869e21e1055d0a65fbf56c61d | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic-Meg|bone_marrow / Manually curated celltypes from each tissue | 2.87e-04 | 180 | 32 | 3 | 44ba37bead1ac39bce4d3eef00961063c50ced0d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 181 | 32 | 3 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-04 | 181 | 32 | 3 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 181 | 32 | 3 | bad77767e64cc093a827a6b0f3f401f3f108e457 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-04 | 181 | 32 | 3 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 182 | 32 | 3 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 182 | 32 | 3 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 182 | 32 | 3 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 182 | 32 | 3 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.01e-04 | 183 | 32 | 3 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 183 | 32 | 3 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-04 | 183 | 32 | 3 | 944f7458b9127356815f75c88bbf7015ebdc8ec1 | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 3.01e-04 | 183 | 32 | 3 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Mesenchymal-Mes-Pericyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-04 | 183 | 32 | 3 | cee6b821adff538078232689965d3e6c131e7d14 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|lymph-node_spleen / Manually curated celltypes from each tissue | 3.06e-04 | 184 | 32 | 3 | f93373fcde5c31f4ffe67ca0f3ea7f4e906dc88b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.06e-04 | 184 | 32 | 3 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 3.06e-04 | 184 | 32 | 3 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.11e-04 | 185 | 32 | 3 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.16e-04 | 186 | 32 | 3 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-04 | 186 | 32 | 3 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-04 | 187 | 32 | 3 | fa8f221b4c2df61eadaa9c77e4cf45848b00330b | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | aa336fb568a24e12c0454265ddd71ed10a6614cf | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 3.21e-04 | 187 | 32 | 3 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 3.21e-04 | 187 | 32 | 3 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 188 | 32 | 3 | 5b69de5baaac45a6d4daa1dbfcb70a7b2ae744ac | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.31e-04 | 189 | 32 | 3 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.36e-04 | 190 | 32 | 3 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.36e-04 | 190 | 32 | 3 | 00ef6ec71353e42260c0d807d7da65b63154c288 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.36e-04 | 190 | 32 | 3 | 18c020ca9a23399214133ec255ab870e0060f2e1 | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.41e-04 | 191 | 32 | 3 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-04 | 191 | 32 | 3 | 1c7d31684654ca6a046d8cc816af1fdc42369c57 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.41e-04 | 191 | 32 | 3 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-04 | 191 | 32 | 3 | d60d81d2045c6e624bbc8b17e13a32f7921d969f | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 7411b253b16e4d472be0925dee49188f0fd6b0b5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 192 | 32 | 3 | d2161842a38146261847fc9061ba9322e0f087e0 | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 3.46e-04 | 192 | 32 | 3 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 192 | 32 | 3 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-04 | 192 | 32 | 3 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 3.46e-04 | 192 | 32 | 3 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.46e-04 | 192 | 32 | 3 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.52e-04 | 193 | 32 | 3 | 5f732598cdb6f3bd519f044a9cc553bd2e8b1052 | |
| ToppCell | URO|World / Disease, Lineage and Cell Type | 3.52e-04 | 193 | 32 | 3 | 421dc0996c6c973f88e90197b651255ae4dd13a2 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.52e-04 | 193 | 32 | 3 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 193 | 32 | 3 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-04 | 193 | 32 | 3 | 5703a6faaee82cbad5ce73429bdf1b0f47b37ee0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-04 | 194 | 32 | 3 | ce0486ce43748ffe486f08fdddd1f6acbfcc6b0e | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 3.57e-04 | 194 | 32 | 3 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-04 | 194 | 32 | 3 | 5022c85ad3b137dae4b9ff11f9c23bb3bf4c0f5a | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.57e-04 | 194 | 32 | 3 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-04 | 194 | 32 | 3 | 449ce4167d64c170d914e0250f739eabedcf915d | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 195 | 32 | 3 | d6e2a5a15bea16de5f7ff09318c67d46ea923203 | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 3.62e-04 | 195 | 32 | 3 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 3.62e-04 | 195 | 32 | 3 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 195 | 32 | 3 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-04 | 195 | 32 | 3 | b0979c1b5e4576468b8fe4e9027650859e598b34 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.62e-04 | 195 | 32 | 3 | 5e12201ce7ba912e7faa123ca200e609252ba288 | |
| Computational | Genes in the cancer module 162. | 8.11e-06 | 19 | 23 | 3 | MODULE_162 | |
| Computational | Genes in the cancer module 218. | 9.53e-06 | 20 | 23 | 3 | MODULE_218 | |
| Drug | beta-alanine | 1.04e-10 | 104 | 32 | 7 | CID000000239 | |
| Drug | nipecotic acid | 1.62e-10 | 57 | 32 | 6 | CID000004498 | |
| Drug | NO-711 | 4.02e-10 | 66 | 32 | 6 | CID000004515 | |
| Drug | guvacine | 5.49e-10 | 30 | 32 | 5 | CID000003532 | |
| Drug | hypotaurine | 6.54e-10 | 31 | 32 | 5 | CID000107812 | |
| Drug | bornane | 1.05e-09 | 11 | 32 | 4 | CID000092108 | |
| Drug | Gaba-Glu | 2.52e-09 | 3 | 32 | 3 | CID000129795 | |
| Drug | ASPAN | 2.52e-09 | 3 | 32 | 3 | CID005475577 | |
| Drug | 2-(2 aminothiazol-4-yl)acetic acid | 1.01e-08 | 4 | 32 | 3 | CID000034665 | |
| Drug | gamma-Aminobutyric Acid | 2.42e-08 | 62 | 32 | 5 | ctd:D005680 | |
| Drug | CI-966 | 2.52e-08 | 5 | 32 | 3 | CID000198692 | |
| Drug | taurine | 2.74e-08 | 231 | 32 | 7 | CID000001123 | |
| Drug | isonipecotic acid | 3.98e-08 | 25 | 32 | 4 | CID000003773 | |
| Drug | AC1Q5UBL | 4.95e-08 | 146 | 32 | 6 | CID000005466 | |
| Drug | 2,4-diaminobutyric acid | 7.44e-08 | 29 | 32 | 4 | CID000000470 | |
| Drug | SKF 100330A | 8.79e-08 | 7 | 32 | 3 | CID000134985 | |
| Drug | somatoprim | 8.79e-08 | 7 | 32 | 3 | CID000001695 | |
| Drug | chlorine cation | 8.79e-08 | 7 | 32 | 3 | CID006857643 | |
| Drug | His-pro-dkp | 9.84e-08 | 31 | 32 | 4 | CID000065137 | |
| Drug | SKF89976A | 9.84e-08 | 31 | 32 | 4 | CID000092409 | |
| Drug | 3-aminopropylphosphinic acid | 1.12e-07 | 32 | 32 | 4 | CID006335948 | |
| Drug | tert-butyl glutaminate | 1.45e-07 | 34 | 32 | 4 | CID003450458 | |
| Drug | sipatrigine | 2.05e-07 | 37 | 32 | 4 | CID000060803 | |
| Drug | thao | 3.01e-07 | 10 | 32 | 3 | CID000127837 | |
| Drug | desvenlafaxine | 3.14e-07 | 41 | 32 | 4 | CID000125017 | |
| Drug | betaine | 3.19e-07 | 200 | 32 | 6 | CID000000247 | |
| Drug | zolpidem | 3.82e-07 | 43 | 32 | 4 | CID000005732 | |
| Drug | gastrodin | 4.13e-07 | 11 | 32 | 3 | CID000115067 | |
| Drug | saclofen | 4.19e-07 | 44 | 32 | 4 | CID000122150 | |
| Drug | isoguvacine | 4.60e-07 | 45 | 32 | 4 | CID000003765 | |
| Drug | amoxapine | 5.03e-07 | 46 | 32 | 4 | CID000002170 | |
| Drug | I Tax | 5.50e-07 | 12 | 32 | 3 | CID000003792 | |
| Drug | kojic amine | 5.50e-07 | 12 | 32 | 3 | CID000003841 | |
| Drug | vigabatrin | 6.51e-07 | 49 | 32 | 4 | CID000005665 | |
| Drug | isoxazole | 1.12e-06 | 56 | 32 | 4 | CID000009254 | |
| Drug | SR 95531 | 1.39e-06 | 59 | 32 | 4 | CID000005275 | |
| Drug | beta-aminobutyric acid | 1.39e-06 | 16 | 32 | 3 | CID000010932 | |
| Drug | picolinic acid | 1.48e-06 | 60 | 32 | 4 | CID000001018 | |
| Drug | pyrrolidine-2,4-dicarboxylate | 1.58e-06 | 61 | 32 | 4 | CID000003868 | |
| Drug | S 254 | 1.69e-06 | 17 | 32 | 3 | CID000029642 | |
| Drug | beta-homoproline | 1.91e-06 | 2 | 32 | 2 | CID000123784 | |
| Drug | furosemide | 1.92e-06 | 272 | 32 | 6 | CID000003440 | |
| Drug | trans-4-aminocrotonic acid | 2.31e-06 | 67 | 32 | 4 | CID000002766 | |
| Drug | N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine | 2.61e-06 | 69 | 32 | 4 | CID000003172 | |
| Drug | di-Z | 2.83e-06 | 20 | 32 | 3 | CID000656933 | |
| Drug | AC1L21VM | 3.30e-06 | 21 | 32 | 3 | CID000039524 | |
| Drug | CGP 52432 | 3.30e-06 | 21 | 32 | 3 | CID000132252 | |
| Drug | hemicholinium-3 | 4.26e-06 | 78 | 32 | 4 | CID000003585 | |
| Drug | trimipramine | 4.71e-06 | 80 | 32 | 4 | CID000005584 | |
| Drug | AC1L1B1W | 5.73e-06 | 84 | 32 | 4 | CID000001248 | |
| Drug | mosapride | 6.41e-06 | 26 | 32 | 3 | CID000119583 | |
| Drug | creatine | 6.95e-06 | 193 | 32 | 5 | CID000000586 | |
| Drug | BBCH | 7.21e-06 | 27 | 32 | 3 | CID000115288 | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 7.68e-06 | 197 | 32 | 5 | 3314_DN | |
| Drug | clobazam | 8.99e-06 | 29 | 32 | 3 | CID000002789 | |
| Drug | FeCl3 | 1.02e-05 | 97 | 32 | 4 | CID000024380 | |
| Drug | acotiamide | 1.90e-05 | 37 | 32 | 3 | CID005282338 | |
| Drug | benzyloxyaspartate | 1.90e-05 | 37 | 32 | 3 | CID004133412 | |
| Drug | Ginkgo biloba | 1.91e-05 | 5 | 32 | 2 | DB01381 | |
| Drug | pyridine-2-aldoxime | 2.41e-05 | 40 | 32 | 3 | CID005356792 | |
| Drug | doxepin | 2.41e-05 | 40 | 32 | 3 | CID000003158 | |
| Drug | N-N-C | 2.79e-05 | 42 | 32 | 3 | CID005278688 | |
| Drug | Niflumic Acid | 2.79e-05 | 42 | 32 | 3 | ctd:D009544 | |
| Drug | muscimol | 3.13e-05 | 129 | 32 | 4 | CID000004266 | |
| Drug | maprotiline | 3.21e-05 | 44 | 32 | 3 | CID000004011 | |
| Drug | 2-amino-5-oxohexanoate | 3.52e-05 | 133 | 32 | 4 | CID000440805 | |
| Drug | OF L | 4.45e-05 | 49 | 32 | 3 | CID000445155 | |
| Drug | gamma-aminobutyric acid | 4.51e-05 | 474 | 32 | 6 | CID000000119 | |
| Drug | benzodiazepine | 4.55e-05 | 142 | 32 | 4 | CID000134664 | |
| Drug | Marathon | 5.63e-05 | 53 | 32 | 3 | CID000034469 | |
| Drug | chloride | 6.76e-05 | 1029 | 32 | 8 | CID000000312 | |
| Drug | AC1LA6XN | 6.85e-05 | 9 | 32 | 2 | CID000462826 | |
| Drug | nortriptyline | 7.77e-05 | 59 | 32 | 3 | CID000004543 | |
| Drug | gabapentin | 8.96e-05 | 169 | 32 | 4 | CID000003446 | |
| Drug | NSC759256 | 9.46e-05 | 63 | 32 | 3 | CID000125889 | |
| Drug | picrotoxin | 1.17e-04 | 181 | 32 | 4 | CID000031304 | |
| Drug | succinic semialdehyde | 1.24e-04 | 69 | 32 | 3 | CID000001112 | |
| Drug | desipramine | 1.35e-04 | 188 | 32 | 4 | CID000002995 | |
| Drug | baclofen | 1.44e-04 | 191 | 32 | 4 | CID000002284 | |
| Drug | Diazepam | 1.53e-04 | 74 | 32 | 3 | ctd:D003975 | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; HL60; HG-U133A | 1.59e-04 | 196 | 32 | 4 | 2033_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 1502_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 3978_DN | |
| Drug | bumetanide | 2.03e-04 | 209 | 32 | 4 | CID000002471 | |
| Drug | AC1L1BXF | 2.30e-04 | 85 | 32 | 3 | CID000001650 | |
| Drug | mianserin | 2.47e-04 | 87 | 32 | 3 | CID000004184 | |
| Drug | sodium | 2.79e-04 | 944 | 32 | 7 | CID000000923 | |
| Drug | pyridine | 3.38e-04 | 239 | 32 | 4 | CID000001049 | |
| Drug | bicuculline methochloride | 3.95e-04 | 21 | 32 | 2 | CID000123659 | |
| Drug | methanethiosulfonate | 4.05e-04 | 103 | 32 | 3 | CID004188587 | |
| Drug | phenobarbital quinidine | 4.34e-04 | 22 | 32 | 2 | ctd:C033457 | |
| Drug | lyso-PAF C16 | 4.34e-04 | 22 | 32 | 2 | CID000003983 | |
| Drug | AC1Q3ZOL | 4.51e-04 | 258 | 32 | 4 | CID000002376 | |
| Drug | flufenamic acid | 4.66e-04 | 108 | 32 | 3 | CID000003371 | |
| Drug | 3-nitro-4-hydroxyphenylacetic acid | 5.18e-04 | 112 | 32 | 3 | CID000447364 | |
| Drug | Toluene | 5.42e-04 | 749 | 32 | 6 | ctd:D014050 | |
| Drug | CCD 1042 | 5.63e-04 | 25 | 32 | 2 | CID000038022 | |
| Drug | 3,4-methylenedioxyethylamphetamine | 5.63e-04 | 25 | 32 | 2 | CID000105039 | |
| Drug | Pilocarpine | 6.56e-04 | 285 | 32 | 4 | ctd:D010862 | |
| Drug | Zidovudine | 7.44e-04 | 521 | 32 | 5 | ctd:D015215 | |
| Disease | level of Phosphatidylethanolamine (O-18:2_20:4) in blood serum | 3.18e-05 | 8 | 32 | 2 | OBA_2045151 | |
| Disease | Schizophrenia | 3.67e-05 | 883 | 32 | 7 | C0036341 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_20:4) in blood serum | 5.10e-05 | 10 | 32 | 2 | OBA_2045148 | |
| Disease | insulin sensitivity measurement | 2.84e-04 | 23 | 32 | 2 | EFO_0004471 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 9.55e-04 | 42 | 32 | 2 | EFO_0022255 | |
| Disease | Bipolar Disorder | 1.69e-03 | 477 | 32 | 4 | C0005586 | |
| Disease | neurofilament light chain measurement | 1.75e-03 | 57 | 32 | 2 | EFO_0009178 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLYIWQVYSCYFLYA | 581 | Q0P6H9 | |
| WSTDEYYYYALAIVV | 226 | Q9H7F0 | |
| YLYKNVCYVNLLFWY | 1116 | O94823 | |
| SYLAYWKSVILEYLY | 901 | Q8WYB5 | |
| LAWAVSYYIRFFITY | 296 | O95864 | |
| YYTLYSVILFCVFFW | 101 | Q9NUN5 | |
| PVVFSFFNIVYWLYY | 496 | P47870 | |
| AFYYLVELQYLWVTY | 76 | Q3SXY7 | |
| YKIWDSYFYLAVIFI | 1001 | Q8N1I0 | |
| FDIYYYVRAWVVFKL | 46 | Q15392 | |
| YFIKWARYNFFIILY | 196 | B0YJ81 | |
| TRTYYIGIVEEYWNY | 26 | Q6MZM0 | |
| LNVFLFVWYYRVYDI | 21 | P04839 | |
| IWILLFVCYYLSYYL | 76 | Q8N0W7 | |
| VVGYGIYYFIYSTWK | 71 | Q96F10 | |
| IYYFIYSTWKGRTIY | 76 | Q96F10 | |
| RIYLVTTYAEFWFYY | 76 | Q96LW4 | |
| VKLKWFYYSTRYVYL | 196 | Q8WU17 | |
| YYNVIIAWSLYYLFS | 151 | P23975 | |
| VYYIVILAWATYYLF | 136 | P31641 | |
| LNIYYIVIISWAIYY | 136 | P30531 | |
| VYYIIILAWALFYLF | 131 | P48065 | |
| VKEYFSWLYYQYQII | 6 | Q8NFR3 | |
| TYYIMVLAWGFYYLV | 146 | P48029 | |
| VVFFIYLYQRWIYRV | 576 | O96005 | |
| FYLWIVFYIISSCYT | 511 | Q9UBH6 | |
| LAWLIFYYIQRFLYT | 216 | Q8NC42 | |
| YKIYFWNIITIAVFY | 441 | Q9NXL6 | |
| YYLVVYYVHILWNEV | 281 | P41440 | |
| NVYYIIVLAWALFYL | 126 | Q9NSD5 | |
| YYIIILAWAIFYLSN | 146 | P48066 | |
| YYGTITWYNIFLVYN | 181 | Q96HH4 | |
| LVIVLVVLWSYYAYV | 26 | Q96MV8 | |
| LYIATTVFSYFIKYW | 186 | Q96MV8 |